Mississippi Advocate Lobbied for Cancer Trial Legislation

Ashleigh Parker urged federal lawmakers to support policies reducing financial barriers to clinical trial access.

Updated on Sept. 26, 2026 in Cancer

Isometric editorial illustration of a medical transport vehicle looking out onto a long rural road, symbolizing clinical trial accessibility challenges.
Cancer advocate Ashleigh Parker lobbied federal lawmakers in September 2026 to pass the Clinical Trial Modernization Act, which would help patients cover travel expenses. AI Illustration. Upload story photo >

Live Poll

Should federal law allow clinical trial sponsors to pay for patient travel and lodging expenses?

Ashleigh Parker, a stage 4 cancer survivor, traveled to Washington in September 2026 to lobby for the Clinical Trial Modernization Act. The legislation aims to help sponsors cover travel and medical costs for participants.

Why it matters

Clinical trials are frequently inaccessible to rural or low-income patients because trial centers are often located hundreds of miles away. The proposed legislation seeks to remove these financial obstacles to improve care access.

Nearly 200 health care and advocacy groups now support the bill, which follows Mississippi passing Jill's Law earlier in 2026. The legislation addresses cost-sharing burdens that current trial structures place on patients.

The players

Ashleigh Parker

She is a stage 4 cancer survivor and the founder of the Mississippi-based advocacy group DeSoto Hope.

Cindy Hyde-Smith

She is a U.S. Senator representing the state of Mississippi.

Roger Wicker

He is a U.S. Senator serving the state of Mississippi.

Trent Kelly

He is a U.S. Representative serving the state of Mississippi.

The details

Parker, who founded the advocacy group DeSoto Hope, met with U.S. Sen. Cindy Hyde-Smith, U.S. Sen. Roger Wicker, and U.S. Rep. Trent Kelly during the American Cancer Society Cancer Action Network leadership summit. She shared her experience, having been diagnosed with Stage 4 colorectal cancer at age 48, to emphasize the need for systemic change in patient support.

Timeline

  1. Ashleigh Parker was diagnosed with Stage 4 colorectal cancer in 2019.

  2. The House version of the Clinical Trial Modernization Act was introduced in May 2025.

  3. The Senate version of the Clinical Trial Modernization Act was introduced in April 2026.

  4. The American Cancer Society Cancer Action Network leadership summit occurred in September 2026.

The Big Picture

This effort aligns with national advocacy surrounding the Clinical Trial Modernization Act to standardize patient support. This movement follows the pattern of state-level successes like Mississippi's Jill's Law, pushing to codify similar protections into federal law.

If passed, the legislation would allow clinical trial sponsors to pay for travel and medical cost-sharing, potentially making life-saving research accessible to more Mississippi residents. This shift would reduce the out-of-pocket expenses for patients currently forced to travel long distances for care.

The takeaway

Legislative advocacy remains a primary driver for systemic changes in how cancer clinical trials are funded and accessed. Patients and their families can influence federal policy by participating in organized lobby days and meeting with state representatives.

Further reading

For additional context on local initiatives, visit the Mississippi Cancer section.

More information

To get involved, learn more about ACS CAN volunteer and advocacy opportunities.

Source note: This article includes information reported by DeSoto County News.

Live Poll

Should federal law allow clinical trial sponsors to pay for patient travel and lodging expenses?